M. T. Kalathottukaren

发表

Antimicrobial Peptide-Polymer Conjugates with High Activity: Influence of Polymer Molecular Weight and Peptide Sequence on Antimicrobial Activity, Proteolysis, and Biocompatibility.

S. Straus, Srinivas Abbina, J. Kizhakkedathu, 2017, ACS applied materials & interfaces.

Influence of Steric Shield on Biocompatibility and Antithrombotic Activity of Dendritic Polyphosphate Inhibitor.

C. Haynes, Srinivas Abbina, J. Kizhakkedathu, 2022, Molecular pharmaceutics.

In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator.

S. Unniappan, Srinivas Abbina, J. Kizhakkedathu, 2016, Biomaterials.

Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors.

C. Haynes, A. Creagh, P. Conley, 2018, Blood advances.

Advantages of replacing hydroxyethyl starch in University of Wisconsin solution with hyperbranched polyglycerol for cold kidney perfusion.

C. Nguan, D. Brooks, J. Kizhakkedathu, 2016, The Journal of surgical research.

Design of Polyphosphate Inhibitors: A Molecular Dynamics Investigation on Polyethylene Glycol-Linked Cationic Binding Groups.

C. Haynes, J. Pfaendtner, K. Chou, 2018, Biomacromolecules.

Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron

Srinivas Abbina, J. Kizhakkedathu, Kendrew S. K. Wong, 2019, ACS central science.

Rheological and clot microstructure evaluation of heparin neutralization by UHRA and protamine.

Haiming Luo, D. Grecov, Srinivas Abbina, 2021, Journal of the mechanical behavior of biomedical materials.

Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.

C. Haynes, F. Rosell, Libin Abraham, 2017, Blood.

Novel anticoagulant neutralizing agents for the management of bleeding : studies on the design, mechanism of action and their influence on blood coagulation

M. T. Kalathottukaren, 2017 .

Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis.

J. Kizhakkedathu, J. Morrissey, R. Travers, 2014, Blood.

Toward Infection-Resistant Surfaces: Achieving High Antimicrobial Peptide Potency by Modulating the Functionality of Polymer Brush and Peptide.

R. Hancock, D. Lange, E. Haney, 2015, ACS applied materials & interfaces.

Mechanisms of blood coagulation in response to biomaterials: Extrinsic factors

J. Kizhakkedathu, M. T. Kalathottukaren, 2018 .

Approaches to prevent bleeding associated with anticoagulants: current status and recent developments

C. Haynes, J. Kizhakkedathu, M. T. Kalathottukaren, 2018, Drug Delivery and Translational Research.

Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants

C. Haynes, D. Brooks, D. Lange, 2014, Science Translational Medicine.

A Polymer Therapeutic Having Universal Heparin Reversal Activity: Molecular Design and Functional Mechanism.

C. Haynes, A. Creagh, Srinivas Abbina, 2017, Biomacromolecules.

Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design

S. Straus, M. Holinstat, E. Conway, 2023, Nature communications.

Approaches to prevent bleeding associated with anticoagulants: current status and recent developments

C. Haynes, J. Kizhakkedathu, M. T. Kalathottukaren, 2017, Drug Delivery and Translational Research.